BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38453743)

  • 1. Development and Validation of Case-Finding Algorithms to Identify Pancreatic Cancer in the Veterans Health Administration.
    Mezzacappa C; Larki NR; Skanderson M; Park LS; Brandt C; Hauser RG; Justice A; Yang YX; Wang L
    Dig Dis Sci; 2024 Apr; 69(4):1507-1513. PubMed ID: 38453743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of case-finding algorithms to identify acute pancreatitis in the Veterans Health Administration.
    Wang LL; Dobkin J; Salgado S; Kaplan DE; Yang YX
    Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1294-1299. PubMed ID: 36222554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Use and Pancreatic Cancer Survival among Non-Hispanic White and African American U.S. Veterans with Diabetes Mellitus.
    Toriola AT; Luo S; Thomas TS; Drake BF; Chang SH; Sanfilippo KM; Carson KR
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):169-175. PubMed ID: 31685560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma.
    Ren S; Tang HJ; Zhao R; Duan SF; Chen R; Wang ZQ
    Curr Med Sci; 2022 Feb; 42(1):217-225. PubMed ID: 35089491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
    Ren S; Zhao R; Zhang J; Guo K; Gu X; Duan S; Wang Z; Chen R
    Abdom Radiol (NY); 2020 May; 45(5):1524-1533. PubMed ID: 32279101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of an algorithm to identify heart failure hospitalisations in patients with diabetes within the veterans health administration.
    Presley CA; Min JY; Chipman J; Greevy RA; Grijalva CG; Griffin MR; Roumie CL
    BMJ Open; 2018 Mar; 8(3):e020455. PubMed ID: 29581206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a pancreatic cancer risk model for the general population using electronic health records: An observational study.
    Appelbaum L; Cambronero JP; Stevens JP; Horng S; Pollick K; Silva G; Haneuse S; Piatkowski G; Benhaga N; Duey S; Stevenson MA; Mamon H; Kaplan ID; Rinard MC
    Eur J Cancer; 2021 Jan; 143():19-30. PubMed ID: 33278770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Stroke Meaningful Use Measures in a National Electronic Health Record System.
    Phipps MS; Fahner J; Sager D; Coffing J; Maryfield B; Williams LS
    J Gen Intern Med; 2016 Apr; 31 Suppl 1(Suppl 1):46-52. PubMed ID: 26951273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Evaluation of a Rules-based Algorithm for Primary Open-Angle Glaucoma in the VA Million Veteran Program.
    Nealon CL; Halladay CW; Kinzy TG; Simpson P; Canania RL; Anthony SA; Roncone DP; Sawicki Rogers LR; Leber JN; Dougherty JM; Sullivan JM; Wu WC; Greenberg PB; Iyengar SK; Crawford DC; Peachey NS; Cooke Bailey JN;
    Ophthalmic Epidemiol; 2022 Dec; 29(6):640-648. PubMed ID: 34822319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Electronic Health Record-Based Algorithms to Identify Specialist Palliative Care Within the Department of Veterans Affairs.
    Feder SL; Zhan Y; Abel EA; Smith D; Ersek M; Fried T; Redeker NS; Akgün KM
    J Pain Symptom Manage; 2023 Oct; 66(4):e475-e483. PubMed ID: 37364737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.
    Debernardi S; O'Brien H; Algahmdi AS; Malats N; Stewart GD; Plješa-Ercegovac M; Costello E; Greenhalf W; Saad A; Roberts R; Ney A; Pereira SP; Kocher HM; Duffy S; Blyuss O; Crnogorac-Jurcevic T
    PLoS Med; 2020 Dec; 17(12):e1003489. PubMed ID: 33301466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
    Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
    JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Maspin, CK17 and Ki-67 Immunophenotyping in Diagnosing of Pancreatic Ductal Adenocarcinoma in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology.
    Mamdouh MM; Okasha H; Shaaban HAM; Hafez NH; El-Gemeie EH
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3299-3307. PubMed ID: 34711007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection.
    Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z
    Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of an algorithm to identify fractures among patients within the Veterans Health Administration.
    Horton TG; Richardson TL; Hackstadt AJ; Halvorson AE; Hung AM; Greevy R; Roumie CL
    Pharmacoepidemiol Drug Saf; 2023 Nov; 32(11):1290-1298. PubMed ID: 37363939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the diagnostic performance of the EFSUMB CEUS Pancreatic Applications guidelines (2017 version): a retrospective single-center analysis of 455 solid pancreatic masses.
    Jia WY; Gui Y; Chen XQ; Zhang XQ; Zhang JH; Dai MH; Guo JC; Chang XY; Tan L; Bai CM; Cheng YJ; Li JC; Lv K; Jiang YX
    Eur Radiol; 2022 Dec; 32(12):8485-8496. PubMed ID: 35699767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma.
    Firpo MA; Boucher KM; Bleicher J; Khanderao GD; Rosati A; Poruk KE; Kamal S; Marzullo L; De Marco M; Falco A; Genovese A; Adler JM; De Laurenzi V; Adler DG; Affolter KE; Garrido-Laguna I; Scaife CL; Turco MC; Mulvihill SJ
    JCO Clin Cancer Inform; 2023 Mar; 7():e2200160. PubMed ID: 36913644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-cell RNA-sequencing.
    Jang SI; Lee HK; Chang EJ; Kim S; Kim SY; Hong IY; Kim JK; Lee HS; Yang J; Cho JH; Lee DK
    Cancer Immunol Immunother; 2023 Aug; 72(8):2757-2768. PubMed ID: 37165046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.